Skip to main content
Top
Published in: Clinical Neuroradiology 2/2023

15-12-2022 | Stroke | Original Article

Clinical and Neuroimaging Characteristics of Ischemic Stroke in Rhino-Orbito-Cerebral Mucormycosis Associated with COVID-19

Authors: Mohammad Amin Najafi, Alireza Zandifar, Neda Ramezani, Hanie Paydari, Mohsen Kheradmand, Behnaz Ansari, Mohammad Reza Najafi, Somayeh Hajiahmadi, Fariborz Khorvash, Mohammad Saadatnia, Arastoo Vossough

Published in: Clinical Neuroradiology | Issue 2/2023

Login to get access

Abstract

Purpose

The aim of this study was to compare clinical, neuroimaging, and laboratory features of rhino-orbito-cerebral mucormycosis (ROCM) in COVID-19 patients with and without ischemic stroke complications.

Methods

This observational study was conducted between August and December 2021 and 48 patients who had confirmed ROCM due to COVID-19, according to neuroimaging and histopathology/mycology evidence were included. Brain, orbit and paranasal sinus imaging was performed in all included patients. Data pertaining to clinical, neuroimaging, and laboratory characteristics and risk factors were collected and compared between patients with and without ischemic stroke complications.

Results

Of the patients 17 were diagnosed with ischemic stroke. Watershed infarction was the most common pattern (N = 13, 76.4%). Prevalence of conventional risk factors of stroke showed no significant differences between groups (patients with stroke vs. without stroke). Cavernous sinus (p = 0.001, odds ratio, OR = 12.8, 95% confidence interval, CI: 2.3–72) and ICA (p < 0.001, OR = 16.31, 95%CI: 2.91–91.14) involvement was more common in patients with stroke. Internal carotid artery (ICA) size (on the affected side) in patients with ischemic stroke was significantly smaller than in patients without stroke (median = 2.4 mm, interquartile range, IQR: 1.3–4 vs. 3.8 mm, IQR: 3.2–4.3, p = 0.004). Superior ophthalmic vein (SOV) size (on the affected side) in patients with stroke was significantly larger than patients without stroke (2.2 mm, IQR: 1.5–2.5 vs. 1.45 mm IQR: 1.1–1.8, p = 0.019). Involvement of the ethmoid and frontal sinuses were higher in patients with stroke (p = 0.007, OR = 1.85, 95% CI: 1.37–2.49 and p = 0.011, OR = 5, 95% CI: 1.4–18.2, respectively). Patients with stroke had higher D‑dimer levels, WBC counts, neutrophil/lymphocyte ratios, and BUN/Cr ratio (all p < 0.05).

Conclusion

Stroke-related ROCM was not associated with conventional ischemic stroke risk factors. Neuroimaging investigations including qualitative and quantitative parameters of cavernous sinus, ICA and SOV are useful to better understand the mechanism of stroke-related ROCM in COVID-19 patients.
Literature
1.
go back to reference Prakash H, Chakrabarti A. Global epidemiology of mucormycosis. J Fungi. 2019;5:26.CrossRef Prakash H, Chakrabarti A. Global epidemiology of mucormycosis. J Fungi. 2019;5:26.CrossRef
2.
go back to reference Ahmadikia K, Hashemi SJ, Khodavaisy S, Getso MI, Alijani N, Badali H, Mirhendi H, Salehi M, Tabari A, Mohammadi Ardehali M, Kord M, Roilides E, Rezaie S. The double-edged sword of systemic corticosteroid therapy in viral pneumonia: a case report and comparative review of influenza-associated mucormycosis versus COVID-19 associated mucormycosis. Mycoses. 2021;64:798–808.CrossRefPubMedPubMedCentral Ahmadikia K, Hashemi SJ, Khodavaisy S, Getso MI, Alijani N, Badali H, Mirhendi H, Salehi M, Tabari A, Mohammadi Ardehali M, Kord M, Roilides E, Rezaie S. The double-edged sword of systemic corticosteroid therapy in viral pneumonia: a case report and comparative review of influenza-associated mucormycosis versus COVID-19 associated mucormycosis. Mycoses. 2021;64:798–808.CrossRefPubMedPubMedCentral
3.
go back to reference Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634–53.CrossRefPubMed Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634–53.CrossRefPubMed
4.
go back to reference Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and diagnosis of mucormycosis: an update. J Fungi. 2020;6:265.CrossRef Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and diagnosis of mucormycosis: an update. J Fungi. 2020;6:265.CrossRef
5.
go back to reference Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr Clin Res Rev. 2021;15:102146.CrossRef Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr Clin Res Rev. 2021;15:102146.CrossRef
6.
go back to reference Srivastava PM, Vishnu VY, Pandit AK. Mucormycosis epidemic and stroke in India during the COVID-19 pandemic. Stroke. 2021;52:e622–e3. Srivastava PM, Vishnu VY, Pandit AK. Mucormycosis epidemic and stroke in India during the COVID-19 pandemic. Stroke. 2021;52:e622–e3.
7.
go back to reference Kulkarni R, Pujari S, Gupta D, Advani S, Soni A, Duberkar D, Dhonde P, Batra D, Bilala S, Agrawal P, Aurangabadkar K. Rhino-orbito-cerebral mycosis and COVID-19: From bad to worse? Ann Indian Acad Neurol. 2022;25:68.CrossRefPubMed Kulkarni R, Pujari S, Gupta D, Advani S, Soni A, Duberkar D, Dhonde P, Batra D, Bilala S, Agrawal P, Aurangabadkar K. Rhino-orbito-cerebral mycosis and COVID-19: From bad to worse? Ann Indian Acad Neurol. 2022;25:68.CrossRefPubMed
8.
go back to reference Kulkarni R, Pujari SS, Gupta D, Ojha P, Dhamne M, Bolegave V, Dhonde P, Soni A, Adwani S, Diwan A, Duberkar D. Cerebrovascular involvement in mucormycosis in COVID-19 pandemic. J Stroke Cerebrovasc Dis. 2022;31:106231.CrossRefPubMed Kulkarni R, Pujari SS, Gupta D, Ojha P, Dhamne M, Bolegave V, Dhonde P, Soni A, Adwani S, Diwan A, Duberkar D. Cerebrovascular involvement in mucormycosis in COVID-19 pandemic. J Stroke Cerebrovasc Dis. 2022;31:106231.CrossRefPubMed
9.
go back to reference Dubey S, Mukherjee D, Sarkar P, Mukhopadhyay P, Barman D, Bandopadhyay M, Pandit A, Sengupta A, Das S, Ghosh S, Adhikari S. COVID-19 associated rhino-orbital-cerebral mucormycosis: an observational study from Eastern India, with special emphasis on neurological spectrum. Diabetes Metab Syndr Clin Res Rev. 2021;15:102267.CrossRef Dubey S, Mukherjee D, Sarkar P, Mukhopadhyay P, Barman D, Bandopadhyay M, Pandit A, Sengupta A, Das S, Ghosh S, Adhikari S. COVID-19 associated rhino-orbital-cerebral mucormycosis: an observational study from Eastern India, with special emphasis on neurological spectrum. Diabetes Metab Syndr Clin Res Rev. 2021;15:102267.CrossRef
10.
go back to reference Mazzai L, Anglani M, Giraudo C, Martucci M, Cester G, Causin F. Imaging features of rhinocerebral mucormycosis: from onset to vascular complications. Acta Radiol. 2022;63:232–44.CrossRefPubMed Mazzai L, Anglani M, Giraudo C, Martucci M, Cester G, Causin F. Imaging features of rhinocerebral mucormycosis: from onset to vascular complications. Acta Radiol. 2022;63:232–44.CrossRefPubMed
11.
go back to reference Hoenigl M, Seidel D, Carvalho A, Rudramurthy SM, Arastehfar A, Gangneux JP, Nasir N, Bonifaz A, Araiza J, Klimko N, Serris A, Lagrou K, Meis JF, Cornely OA, Perfect JR, White PL, Chakrabarti A; ECMM and ISHAM collaborators. The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. Lancet Microbe. 2022;3:e543–52.CrossRefPubMedPubMedCentral Hoenigl M, Seidel D, Carvalho A, Rudramurthy SM, Arastehfar A, Gangneux JP, Nasir N, Bonifaz A, Araiza J, Klimko N, Serris A, Lagrou K, Meis JF, Cornely OA, Perfect JR, White PL, Chakrabarti A; ECMM and ISHAM collaborators. The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. Lancet Microbe. 2022;3:e543–52.CrossRefPubMedPubMedCentral
13.
go back to reference Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35–41.CrossRefPubMed Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35–41.CrossRefPubMed
14.
go back to reference Chikley A, Ben-Ami R, Kontoyiannis DP. Mucormycosis of the central nervous system. J Fungi. 2019;5:59.CrossRef Chikley A, Ben-Ami R, Kontoyiannis DP. Mucormycosis of the central nervous system. J Fungi. 2019;5:59.CrossRef
15.
go back to reference Hosseini SM, Borghei P. Rhinocerebral mucormycosis: pathways of spread. Eur Arch Otorhinolaryngol. 2005;262:932–8.CrossRefPubMed Hosseini SM, Borghei P. Rhinocerebral mucormycosis: pathways of spread. Eur Arch Otorhinolaryngol. 2005;262:932–8.CrossRefPubMed
16.
go back to reference Little JS, Cheng MP, Hsu L, Corrales CE, Marty FM. Invasive Fungal Carotiditis: A Rare Manifestation of Cranial Invasive Fungal Disease: Case Series and Systematic Review of the Literature. Open Forum Infect Dis. 2019;6:ofz392.CrossRefPubMedPubMedCentral Little JS, Cheng MP, Hsu L, Corrales CE, Marty FM. Invasive Fungal Carotiditis: A Rare Manifestation of Cranial Invasive Fungal Disease: Case Series and Systematic Review of the Literature. Open Forum Infect Dis. 2019;6:ofz392.CrossRefPubMedPubMedCentral
17.
go back to reference Sotoudeh H, Shafaat O, Aboueldahab N, Vaphiades M, Sotoudeh E, Bernstock J. Superior ophthalmic vein thrombosis: What radiologist and clinician must know? Eur J Radiol Open. 2019;6:258–64.CrossRefPubMedPubMedCentral Sotoudeh H, Shafaat O, Aboueldahab N, Vaphiades M, Sotoudeh E, Bernstock J. Superior ophthalmic vein thrombosis: What radiologist and clinician must know? Eur J Radiol Open. 2019;6:258–64.CrossRefPubMedPubMedCentral
18.
go back to reference Makkat S, Vandevenne JE, Verswijvel G, Ijsewijn T, Grieten M, Palmers Y, De Schepper AM, Parizel PM. Signs of acute stroke seen on fluid-attenuated inversion recovery MR imaging. AJR Am J Roentgenol. 2002;179:237–43.CrossRef Makkat S, Vandevenne JE, Verswijvel G, Ijsewijn T, Grieten M, Palmers Y, De Schepper AM, Parizel PM. Signs of acute stroke seen on fluid-attenuated inversion recovery MR imaging. AJR Am J Roentgenol. 2002;179:237–43.CrossRef
19.
go back to reference Lee WH, Kim JW, Lim JS, Kong IG, Choi HG. Chronic rhinosinusitis increases the risk of hemorrhagic and ischemic stroke: A longitudinal follow-up study using a national sample cohort. PLoS ONE. 2018;13:e193886.CrossRefPubMedPubMedCentral Lee WH, Kim JW, Lim JS, Kong IG, Choi HG. Chronic rhinosinusitis increases the risk of hemorrhagic and ischemic stroke: A longitudinal follow-up study using a national sample cohort. PLoS ONE. 2018;13:e193886.CrossRefPubMedPubMedCentral
20.
go back to reference Klein DE, Libman R, Kirsch C, Arora R. Cerebral venous thrombosis: atypical presentation of COVID-19 in the young. J Stroke Cerebrovasc Dis. 2020;29:104989.CrossRefPubMedPubMedCentral Klein DE, Libman R, Kirsch C, Arora R. Cerebral venous thrombosis: atypical presentation of COVID-19 in the young. J Stroke Cerebrovasc Dis. 2020;29:104989.CrossRefPubMedPubMedCentral
21.
go back to reference Ok F, Erdogan O, Durmus E, Carkci S, Canik A. Predictive values of blood urea nitrogen/creatinine ratio and other routine blood parameters on disease severity and survival of COVID-19 patients. J Med Virol. 2021;93:786–93.CrossRefPubMed Ok F, Erdogan O, Durmus E, Carkci S, Canik A. Predictive values of blood urea nitrogen/creatinine ratio and other routine blood parameters on disease severity and survival of COVID-19 patients. J Med Virol. 2021;93:786–93.CrossRefPubMed
22.
go back to reference Liu Q, Wang Y, Zhao X, Wang L, Liu F, Wang T, Ye D, Lv Y. Diagnostic performance of a blood urea nitrogen to creatinine ratio-based nomogram for predicting in-hospital mortality in COVID-19 patients. Risk Manag Healthc Policy. 2021;14:117.CrossRefPubMedPubMedCentral Liu Q, Wang Y, Zhao X, Wang L, Liu F, Wang T, Ye D, Lv Y. Diagnostic performance of a blood urea nitrogen to creatinine ratio-based nomogram for predicting in-hospital mortality in COVID-19 patients. Risk Manag Healthc Policy. 2021;14:117.CrossRefPubMedPubMedCentral
Metadata
Title
Clinical and Neuroimaging Characteristics of Ischemic Stroke in Rhino-Orbito-Cerebral Mucormycosis Associated with COVID-19
Authors
Mohammad Amin Najafi
Alireza Zandifar
Neda Ramezani
Hanie Paydari
Mohsen Kheradmand
Behnaz Ansari
Mohammad Reza Najafi
Somayeh Hajiahmadi
Fariborz Khorvash
Mohammad Saadatnia
Arastoo Vossough
Publication date
15-12-2022
Publisher
Springer Berlin Heidelberg
Published in
Clinical Neuroradiology / Issue 2/2023
Print ISSN: 1869-1439
Electronic ISSN: 1869-1447
DOI
https://doi.org/10.1007/s00062-022-01238-y

Other articles of this Issue 2/2023

Clinical Neuroradiology 2/2023 Go to the issue